Education
About Us
Working with TipRanks
Follow Us
Alterola Biotech Inc. (ABTI)
:ABTI
Total Valuation
Alterola Biotech has a market cap or net worth of $291.90M. The enterprise value is $36.64M.
Market Cap$291.90M
Enterprise Value$36.64M
Share Statistics
Alterola Biotech has 1,459,502,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,459,502,100
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Alterola Biotech’s return on equity (ROE) is -0.15 and return on invested capital (ROIC) is -14.98%.
Return on Equity (ROE)-0.15
Return on Assets (ROA)-0.12
Return on Invested Capital (ROIC)-14.98%
Return on Capital Employed (ROCE)-0.19
Revenue Per Employee0.00
Profits Per Employee-1.74M
Employee Count1
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Alterola Biotech is -22.84. Alterola Biotech’s PEG ratio is 0.30.
PE Ratio-22.84
PS Ratio0.00
PB Ratio3.49
Price to Fair Value3.49
Price to FCF-29.87
Price to Operating Cash Flow-33.89
PEG Ratio0.30
Income Statement
In the last 12 months, Alterola Biotech had revenue of 0.00 and earned -1.54M in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit0.00
Operating Income-1.90M
Pretax Income-1.70M
Net Income-1.54M
EBITDA-1.70M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -874.20K and capital expenditures -18.90K, giving a free cash flow of -893.10K billion.
Operating Cash Flow-874.20K
Free Cash Flow-893.10K
Free Cash Flow per Share>-0.01
Dividends & Yields
Alterola Biotech pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-30.29
52-Week Price Change900.00%
50-Day Moving Average0.01
200-Day Moving Average―
Relative Strength Index (RSI)94.85
Average Volume (3m)16.76K
Important Dates
Alterola Biotech upcoming earnings date is ―, TBA Not Confirmed.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Alterola Biotech as a current ratio of 0.11, with Debt / Equity ratio of 14.01%
Current Ratio0.11
Quick Ratio0.11
Debt to Market Cap0.04
Net Debt to EBITDA-0.83
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Alterola Biotech has paid -154.52K in taxes.
Income Tax-154.52K
Effective Tax Rate0.09
Enterprise Valuation
Alterola Biotech EV to EBITDA ratio is -21.59, with an EV/FCF ratio of -31.06.
EV to Sales0.00
EV to EBITDA-21.59
EV to Free Cash Flow-31.06
EV to Operating Cash Flow-35.24
Balance Sheet
Alterola Biotech has $9.10K in cash and marketable securities with $1.55M in debt, giving a net cash position of $1.54M billion.
Cash & Marketable Securities$9.10K
Total Debt$1.55M
Net Cash$1.54M
Net Cash Per Share<$0.01
Tangible Book Value Per Share>-$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Alterola Biotech is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―